Komen Breast
Cancer Charity Cancels Races in 7 Cities
The Susan G.
Komen for the Cure foundation has canceled half of its “3-Day” fund-raising
races around the country next year as it struggles to regain support nearly 18
months after its 2012 decision to withdraw funding for breast cancer screening
at some Planned Parenthood affiliates.
By Jennifer Preston. In New York Times (blog)
Nontoxic
cancer therapy proves effective against metastatic cancer
A
combination of nontoxic dietary and hyperbaric oxygen therapies effectively
increased survival time in a mouse model of aggressive metastatic cancer, a
research team from the Hyperbaric Biomedical Research Laboratory at the
University of South Florida has found.
In Science
Daily
Cancer
treatments still caught in sequestration politics
The
Obama administration says it does not have the power to ease the cuts, leaving
it to Congress to act.
By Katie McDonough. In Salon
Genetic
Testing of Rare Blood Cancer Reveals New Mutation
A recent
article in the New England Journal of Medicine
describes genetic testing of a rare blood cancer called atypical chronic
neutrophilic leukemia (CNL) that revealed a new mutation present in most
patients with the disease. The mutation also serves as an Achilles heel,
allowing doctors at the University
of Colorado Cancer Center
to prescribe a never-before-used, targeted treatment. The first patient treated
describes his best snowboarding season ever.
In Science
Daily
World’s
Oldest Cancer Found in Bone of 120,000 Year-Old Neanderthal
The world's
oldest known human tumour has been found in the rib bone of a Neanderthal who
lived more than 120,000 years ago.
The bone was
evacuated from a site in Krapina ,
Croatia more
than 100 years ago and has been found to have contracted the fibrous dysplasia tumour, a cancer which is common among
modern-day humans.
By Ewan Palmer. In International Business Times
Une nouvelle arme contre le cancer
du col de l'utérus ?
Des chercheurs viennent de mettre au
point une stratégie pour stopper le développement du cancer du col de l’utérus,
causé par certains papillomavirus. Cette méthode est basée sur l’utilisation
d’une molécule d’ARN synthétique qui bloque l’action d’une protéine virale.
Par Agnès Roux. Dans Futura-Sciences
Le rôle de l'oestrogène mieux
compris dans le cancer colorectal
Le cancer colorectal touche surtout
les personnes de plus de 50 ans, un peu plus d'hommes que de femmes. C'est un
cancer qui se développe sur plusieurs années – parfois même sur 20 ans – et qui
reste discret très longtemps. En 2012 au Québec, on estime qu'il y a eu quelque
6200 nouveaux cas diagnostiqués et environ 2400 décès. Les facteurs de risque
peuvent varier: polypes colorectaux, antécédents familiaux, mauvaises habitudes
alimentaires (trop de viande rouge, pas assez de fruits et légumes), manque
d'exercice physique et obésité. L'importance de la recherche sur le cancer
colorectal est donc implicite.
Dans Techno-science.net
Aucun commentaire:
Enregistrer un commentaire